[3] Synthesis of chemokines by native chemical ligation

Methods in Enzymology

Volumn 287, Issue , 1997, Pages 34-45

  Dawson, Philip E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYSTEINE PROTEINASE; THIOESTER PEPTIDE; UNCLASSIFIED DRUG; DISULFIDE; INTERLEUKIN 8; PEPTIDE; THIAZOLE DERIVATIVE; THIOL DERIVATIVE;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; ISOLATION PROCEDURE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REACTION ANALYSIS; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MOLECULAR GENETICS; PROTEIN FOLDING; SYNTHESIS;

AMINO ACID SEQUENCE; CHEMOKINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISULFIDES; INTERLEUKIN-8; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN FOLDING; SULFHYDRYL COMPOUNDS; THIAZOLES;

EID: 0030632227     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(97)87005-X     Document Type: Article

References (34)

1. R. B. Merrifield, J. Am. Chem. Soc. 85, 2149 (1963).
2. T. W. Muir and S. B. H. Kent, Curr. Opin. Biotechnol. 4, 420 (1992).
3. I. Clark-Lewis, L. Vo, P. Owen, and J. Anderson, Methods Enzymol. 287 [16], 1997 (this volume).
4. I. Clark-Lewis, B. Dewald, M. Loetscher, B. Moser, and M. Baggiolini, J. Biol. Chem. 269, 16075 (1994).
5. M. Schnölzer and S. B. H. Kent, Science 256, 221 (1992).
6. K. Rose, J. Am. Chem. Soc. 116, 30 (1994).
7. J. Shao and J. P. Tam, J. Am. Chem. Soc. 117, 3893 (1995).
8. C.-F. Liu, C. Rao, and J. P. Tam, J. Am. Chem. Soc. 118, 307 (1996).
9. D. R. Englebretsen, B. G. Garnham, D. A. Bergman, and P. F. Alewood, Tetrahedron Lett. 36, 8871 (1995).
10. M. Baca, T. W. Muir, M. Schnölzer, and S. B. H. Kent, J. Am. Chem. Soc. 117, 1881 (1995).
11. L. E. Canne, A. R. Ferre-D'Amare, S. K. Burley, and S. B. H. Kent, J. Am. Chem. Soc. 117, 2998 (1992).
12. P. E. Dawson, T. W. Muir, I. Clark-Lewis, and S. B. H. Kent, Science 266, 776 (1994).
13. T. Wieland, E. Bokelmann, L. Bauer, H. U. Lang, and H. Lau, Liebigs Ann. Chem. 583, 129 (1953).
14. P. E. Dawson, M. Churchill, R. M. Ghadiri, and S. B. H. Kent, J. Am. Chem. Soc. 119, 4325 (1997).
15. 12
16. Phosphines have also been added during ligation as a reducing agent. J. P. Tam, Proc. Natl. Acad. Sci. U.S.A. 92, 12485 (1995).
17. A promising extension has been reported that permits Gly-Xaa and Xaa-Gly sites to be utilized. This extension has not yet been applied to proteins [L. E. Canne, S. J. Bark, and S. B. H. Kent, J. Am. Chem. Soc. 118, 55891 (1996)].
18. D. Sali, M. Bycroft, and A. R. Fersht, J. Mol. Biol. 220, 779 (1991).
19. S. S. Wong, "Chemistry of Protein Conjugation and Cross-Linking." CRC Press, Boca Raton, Florida, 1991.
20. W. Lu, M. A. Qasim, and S. B. H. Kent, J. Am. Chem. Soc. 118, 8518 (1996).
21. M. A. Siani, D. A. Thompson, L. E. Canne, G. M. Figliozzi, B. Robson, S. B. H. Kent, and R. J. Simon, poster presented at the IB3 Chemokines 3 Conference, San Francisco, California, October 1996
22. M. Schnolzer, P. Alewood, D. Alewood, and S. B. H. Kent, Int. J. Pept. Protein Res. 85, 180 (1992).
23. Fmoc chemistry has not been utilized because of the susceptibility of thioester peptides to aminolysis by piperidine. Use of a resin designed to be cleaved by nucleophiles following synthesis may allow thioester peptides to be synthesized by Fmoc protocols.
24. Small amounts of alkylation of the tryptophan side chain are observed during synthesis. In principle, the formyl protecting group could be removed either following or during ligation.
25. T. Hackeng, personal communication (1996).
26. J. Blake, Int. J. Pep. Protein Res. 17, 273 (1981).
27. L. E. Canne, S. M. Walker, and S. B. H. Kent, Tetrahedron Lett. 36, 1217 (1995).
28. A. R. Mitchell, S. B. H. Kent, B. W. Erickson, and R. B. Merifield, Tetrahedron Lett. 42, 3795 (1976).
29. J. Tam, Methods Enzymol. 146, 127 (1987).
30. V. K. Sarin, S. B. H. Kent, J. P. Tam, and R. B. Merrifield, Anal. Biochem. 117, 147 (1981).
31. The alkylation reaction can also be performed using benzyl bromide as the alkylating agent, producing a benzyl thioester peptide. Complications can arise owing to the poor solubility of benzyl mercaptan in aqueous solutions and its greater reactivity toward the peptide side chains.
32. H. Hojo, Y. Kwon, Y. Kakuta, S. Tsuda, I. Tanaka, K. Hikichi, and S. Aimoto, Bull. Chem. Soc. Jpn. 66, 2700 (1993).
33. During ligation, a white precipitate may form in the ligation mixture. This is a result of oxidation of thiophenol and benzyl mercaptan and can be removed after ligation by filtration.
34. M. C. Fitzgerald, personal communication (1996).